semaglutide cardiovascular protects heart beyond weight loss benefits Oral Semaglutide Approved to Reduce

Moreover, an East-Asian MR study (N = 11,506) reported a probable causal effect of T2DM on MDD [62]

We can then decide whether you should continue the treatment or whether a change in the dosage of the recommended active substance is necessary

Symptoms such as orthopnoea (breathlessness when lying flat), paroxysmal nocturnal dyspnoea, or ankle oedema suggest cardiac causes

Substantial weight reduction, regardless of the method, can lead to decreased bone mineral density, particularly at weight-bearing sites such as the hip and spine

Oral tirzepatide is not appropriate for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)